86 related articles for article (PubMed ID: 14688030)
1. o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.
Sills RC; Hong HL; Flake G; Moomaw C; Clayton N; Boorman GA; Dunnick J; Devereux TR
Carcinogenesis; 2004 Apr; 25(4):605-12. PubMed ID: 14688030
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
Zhuang SM; Wiseman RW; Söderkvist P
Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
[TBL] [Abstract][Full Text] [Related]
3. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
[TBL] [Abstract][Full Text] [Related]
4. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
5. Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years.
Hong HL; Ton TV; Devereux TR; Moomaw C; Clayton N; Chan P; Dunnick JK; Sills RC
Toxicol Appl Pharmacol; 2003 Sep; 191(3):227-34. PubMed ID: 13678655
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
[TBL] [Abstract][Full Text] [Related]
7. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.
Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K
Carcinogenesis; 2005 Jan; 26(1):229-38. PubMed ID: 15459021
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
[TBL] [Abstract][Full Text] [Related]
9. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability.
Guda K; Upender MB; Belinsky G; Flynn C; Nakanishi M; Marino JN; Ried T; Rosenberg DW
Oncogene; 2004 May; 23(21):3813-21. PubMed ID: 15021908
[TBL] [Abstract][Full Text] [Related]
12. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
13. Analysis of beta-catenin, Ki-ras, and microsatellite stability in azoxymethane-induced colon tumors of BDIX/Orl Ico rats.
Sørensen NM; Kobaek-Larsen M; Bonne A; van Zutphen B; Fenger C; Kristiansen K; Ritskes-Hoitinga M
Comp Med; 2003 Dec; 53(6):633-8. PubMed ID: 14727811
[TBL] [Abstract][Full Text] [Related]
14. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
15. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
[TBL] [Abstract][Full Text] [Related]
16. Absence of p53 gene mutations in mice colon pre-cancerous stage induced by o-nitrotoluene.
Hussien NA
J Cancer Res Ther; 2014; 10(4):1008-12. PubMed ID: 25579545
[TBL] [Abstract][Full Text] [Related]
17. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
18. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice.
Belaïdouni N; Peuchmaur M; Perret C; Florentin A; Benarous R; Besnard-Guérin C
Oncogene; 2005 Mar; 24(13):2271-6. PubMed ID: 15735746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
